The effect of clodronate on the incidence of hip fracture and consequences for health and costs

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN39259790

Enrollment

5700

Registered

2000-10-25

Start date

1996-06-10

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopaedics, rheumatology Musculoskeletal Diseases Hip fracture

Interventions

Clodronate/control

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women aged 75 years or older willing to participate

Exclusion criteria

Exclusion criteria: Drugs and diseases likely to impair the efficacy of intervention or the interpretation of results

Design outcomes

Primary

Measure	Time frame
Fragility fractures, particularly hip fracture	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026